Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
Vaccines and immunotherapeutic approaches to cancers with the advent of immune checkpoint inhibitors and chimeric antigen receptor-modified T cells have recently demonstrated preclinical success and entered clinical trials. Despite advances in these approaches and combinatorial therapeutic regimens,...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2017-06-01
|
| Серія: | Frontiers in Oncology |
| Предмети: | |
| Онлайн доступ: | http://journal.frontiersin.org/article/10.3389/fonc.2017.00136/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|